Condition: Prostate Cancer, Localized Prostate Carcinoma

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT06003556

Sponsor: University of Alberta

Phase: Phase 2

Eligibility:

• Age: minimum 50 Years maximum N/A
• Gender: Male

Inclusion Criteria:

1. Age > 50
2. Clinical stage < T2b
3. PSA < 15
4. Combined targeted and systematic MRI-guided biopsy shows unilateral Gleason Grade Group 2 or 3 prostate cancer

Exclusion Criteria:

1. Unable to obtain consent
2. Weight >250 kg (weight limitation of scanners)
3. Unable to lie flat for 30 minutes to complete the PET imaging
4. Lack of intravenous access
5. eGFR < 40 mL/min/1.73 m2 and/or a history of a severe reaction to CT contrast
6. Prior androgen deprivation therapy or radiation therapy to prostate gland

View trial on ClinicalTrials.gov